Hao et al. [87] discussed the potential of the dimeric peptoid GU40C4, a potent VEGFR-2 antagonist that inhibits angiogenesis and tumor growth, as a PET imaging agent for VEGFR-2 expression. The gene discussed is KDR; the disease is neoplasm.